Carregant...

Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis

Objective This study represents the first 10 year analysis of the efficacy and toxicity of stereotactic body radiotherapy (SBRT) in the treatment of early low-risk prostate cancer. Materials and methods Two hundred and thirty males were treated with Cyberknife SBRT to a dose of 35 Gray (Gy) or 36.25...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cureus
Autor principal: Katz, Alan
Format: Artigo
Idioma:Inglês
Publicat: Cureus 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679773/
https://ncbi.nlm.nih.gov/pubmed/29152425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1668
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!